Asthma Trial, Recruiting NCT05272241 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05272241
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are willing and able to give their own consent to participate at the time of enrollment
  • People under 18 years old, as long as a legal guardian is present and willing to give consent on their behalf at the time of enrollment
  • People whose main home address is located within a Metropolitan Statistical Area (MSA) as defined by the Office of Management and Budget (confirm with trial site for details on whether a specific area qualifies)

Who may not be able to join:

  • People whose primary language is not English or Spanish, or whose legal guardian does not speak English or Spanish
  • People who do not have regular access to a phone — whether personal or shared/public — that could be used for scheduling and safety check-ins
  • People with past or current health conditions, or results from physical exams or lab tests, that the trial doctor considers may create extra risks, interfere with the ability to follow the study requirements, or affect the quality of the study data (confirm with trial site)

Additional notes:

  • People who are pregnant or breastfeeding are not automatically excluded, but certain procedures — such as allergen skin testing and breathing tests — would not be performed during pregnancy, as outlined in the study's guidelines
  • People who are not eligible at first assessment may be able to be reassessed at a later time, as outlined in the study protocol (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 April 2022
Est. completion
1 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants with asthma and allergy characteristics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov